Accelerate Diagnostics Key Fundamental Indicators
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
As of the 17th of February 2026, Accelerate Diagnostics shows the risk adjusted performance of (0.22), and Mean Deviation of 6.5. Accelerate Diagnostics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Accelerate Diagnostics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Accelerate Diagnostics' valuation are provided below:Accelerate Diagnostics does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Accelerate |
Search Suggestions
| AX | Axos Financial | Company |
| AXS-PE | AXIS Capital Holdings | Company |
| AXBIX | Intermediate Term Tax Free Bond | Mutual Fund |
| AXDI | BlackRock | ETF |
| AXS | Axie Infinity Shards | Cryptocurrency |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 38.3% of Accelerate Diagnostics are shares owned by insiders. This is 152.31% higher than that of the Health Care Equipment & Supplies sector and 146.3% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Accelerate Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Accelerate Diagnostics's current stock value. Our valuation model uses many indicators to compare Accelerate Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accelerate Diagnostics competition to find correlations between indicators driving Accelerate Diagnostics's intrinsic value. More Info.Accelerate Diagnostics is rated below average in return on asset category among its peers. It is rated fourth in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Accelerate Diagnostics' earnings, one of the primary drivers of an investment's value.Accelerate Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Accelerate Diagnostics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Accelerate Diagnostics could also be used in its relative valuation, which is a method of valuing Accelerate Diagnostics by comparing valuation metrics of similar companies.Accelerate Diagnostics is currently under evaluation in shares owned by insiders category among its peers.
Accelerate Fundamentals
| Return On Asset | -0.74 | |||
| Operating Margin | (2.82) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 25.29 M | |||
| Shares Owned By Insiders | 38.30 % | |||
| Shares Owned By Institutions | 17.91 % | |||
| Number Of Shares Shorted | 297.38 K | |||
| Price To Earning | (15.18) X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 11.7 M | |||
| Gross Profit | 2.7 M | |||
| EBITDA | (33.57 M) | |||
| Net Income | (50.05 M) | |||
| Cash And Equivalents | 36.77 M | |||
| Cash Per Share | 0.45 X | |||
| Total Debt | 66.58 M | |||
| Debt To Equity | 2.76 % | |||
| Current Ratio | 4.48 X | |||
| Book Value Per Share | (2.23) X | |||
| Cash Flow From Operations | (24.19 M) | |||
| Short Ratio | 6.15 X | |||
| Earnings Per Share | (2.15) X | |||
| Price To Earnings To Growth | (0.55) X | |||
| Target Price | 1.5 | |||
| Number Of Employees | 107 | |||
| Beta | 0.22 | |||
| Market Capitalization | 859.92 K | |||
| Total Asset | 28.56 M | |||
| Retained Earnings | (718.9 M) | |||
| Working Capital | (8.96 M) | |||
| Current Asset | 91.68 M | |||
| Current Liabilities | 4.45 M | |||
| Net Asset | 28.56 M |
About Accelerate Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Accelerate Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accelerate Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accelerate Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. Accelerate Diagnosti operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 220 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |